These data show that NKp46 can endow NK cells or ILC1 with the ability to lyse TRAIL-sensitive tumors as well as contribute to TRAIL-mediated immunoregulation of infectious diseases, tissue inflammation (144–146), and potentially autoimmunity. This evidence concerns the gene NCR1 and infectious disease.